SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001104659-11-068626
Filing Date
2011-12-09
Accepted
2011-12-09 16:07:27
Documents
1
Period of Report
2011-11-22

Document Format Files

Seq Description Document Type Size
1 4/A a4a.html 4/A  
1 4/A a4a.xml 4/A 6473
  Complete submission text file 0001104659-11-068626.txt   8611
Mailing Address LICHTSTRASSE 35 CH-4002 BASEL V8
Business Address LICHTSTRASSE 35 CH-4002 BASEL V8 212-830-2474
NOVARTIS PHARMA AG (Reporting) CIK: 0001030617 (see all company filings)

Type: 4/A | Act: 34 | File No.: 000-49839 | Film No.: 111253575

Mailing Address 60 HAMPSHIRE STREET CAMBRIDGE MA 02139
Business Address 60 HAMPSHIRE STREET CAMBRIDGE MA 02139 617-995-9800
IDENIX PHARMACEUTICALS INC (Issuer) CIK: 0001093649 (see all company filings)

IRS No.: 450478605 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address LICHSTRASSE 35 BASEL SWITZERLAND CH 4056
Business Address LICHSTRASSE 35 BASEL SWITZERLAND V8 CH 4056
NOVARTIS AG (Reporting) CIK: 0001114448 (see all company filings)

Fiscal Year End: 1231
Type: 4/A | Act: 34 | File No.: 000-49839 | Film No.: 111253576
SIC: 2834 Pharmaceutical Preparations